U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 11 - 12 of 12 results

Lactiplantibacillus plantarum 299V

MORE DETAILS

PH2Q4E64WM

structurally diverse
Status:
Possibly Marketed Outside US
Source:
Bolsitol by PureTek Corporation
(2023)
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=29b537f2-19c9-4f15-9b81-53674503419f
First approved in 2023
Source:
Bolsitol by PureTek Corporation
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=29b537f2-19c9-4f15-9b81-53674503419f
Class:
STRUCTURALLY DIVERSE

Lactiplantibacillus plantarum

MORE DETAILS

QFC21096ON

structurally diverse
Status:
Possibly Marketed Outside US
Source:
Carecne by Biorhythm Co., Ltd
Source URL:
https://www.drugbank.ca/drugs/DB11360
First approved in 2015
Source:
Kimchi Lactic Acid 1000 by Biogenicskorea Co., LTD
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a4f76c61-aec7-4e80-88f2-330a8a4cda11
Class:
STRUCTURALLY DIVERSE

Showing 11 - 12 of 12 results

NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966